![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
A Review of Energy Modalities Used for Focal Therapy of Prostate Cancer
Prostate cancer (PCa) is a prevalent cancer among men that needs effective treatment approaches. Traditionally, PCa was managed through whole-gland radical therapy or Active Surveillance. However, the field ha...
-
Article
Real-Time and Delayed Imaging of Tissue and Effects of Prostate Tissue Ablation
Prostate ablation is increasingly being utilized for the management of localized prostate cancer. There are several energy modalities with varying mechanism of actions which are currently used for prostate abl...
-
Article
Moving away from systematic biopsies: image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) —literature review
To compare the detection rate of clinically significant cancer (CSCa) by magnetic resonance imaging-targeted biopsy (MRI-TB) with that by standard systematic biopsy (SB) and to evaluate the role of MRI-TB as a...
-
Article
Is a targeted biopsy-only approach for prostate cancer diagnosis ready for the prime time?
The PRECISION trial demonstrated the ability of using multiparametric MRI to improve the diagnosis of clinically significant prostate cancer whilst reducing over-diagnosis of clinically insignificant cancer co...
-
Article
Imaging for prostate cancer: reimbursements
-
Article
Racial disparity in the utilization of multiparametric MRI–ultrasound fusion biopsy for the detection of prostate cancer
Black men have significantly higher incidence and are up to three times more likely to die of prostate cancer (PCa) than White men. Multiparametric magnetic resonance imaging-ultrasound fusion biopsy (FBx) has...
-
Article
Hypogonadism and prostate cancer detection on multiparametric MRI and mpMRI-TRUS fusion biopsy
Currently, there is a dearth of data concerning the impact of hypogonadism on prostate cancer detection by imaging. In this study, we evaluated the performance of multiparametric MRI (mpMRI) and mpMRI-TRUS fus...
-
Article
Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma
The clinical role of fluorine-18 fluoro-2-deoxyglucose (FDG)-positron emission tomography (PET) in renal cell carcinoma (RCC) is still evolving. Use of FDG PET in RCC is currently not a standard investigation ...
-
Article
Index tumor volume on MRI as a predictor of clinical and pathologic outcomes following radical prostatectomy
Index tumor volume (ITV) measured on radical prostatectomy (RP) specimens has been shown to be associated with adverse pathologic and oncologic outcomes. We evaluate the value of ITV calculated from prostate m...
-
Article
Salvage treatment for radio-recurrent prostate cancer: a review of literature with focus on recent advancements in image-guided focal salvage therapies
Biochemical recurrence of prostate cancer occurs in 25–33% of patients who undergo radiation therapy (RT). Unfortunately, greater than 90% of patients with radiation recurrence undergo androgen deprivation the...
-
Article
Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database
Population studies of patients undergoing radical cystectomy (RC) for bladder cancer (BC) suggest that a more extended lymph node dissection (LND) increases survival. However, information regarding LNDs of pat...
-
Article
Ruling out clinically significant prostate cancer with negative multi-parametric MRI
To evaluate the negative predictive value (NPV) of a negative prostate multi-parametric magnetic resonance imaging (mpMRI) in ruling out clinically significant prostate upon 12-core systematic biopsy.
-
Article
Current Role of Magnetic Resonance Imaging in Prostate Cancer
Multiparametric magnetic resonance imaging of the prostate (mpMRI) is a new rising diagnostic modality in prostate cancer management. The combination of anatomic and functional sequences allows for detection, ...
-
Article
Re: Csaba Berczi, Ben Thomas, Zsolt Bacso, Tibor Flasko. Bilateral renal cancers: oncological and functional outcomes. Int Urol Nephrol 2016 (Epub ahead of print)
-
Article
Midline lesions of the prostate: role of MRI/TRUS fusion biopsy and implications in Gleason risk stratification
MRI-TRUS fusion biopsy (FBx) has proven efficacy in targeting suspicious areas that are traditionally missed by systematic 12-core biopsy (SBx). Midline prostate lesions are undersampled during SBx, as traditi...
-
Article
Postoperative elevation in creatine kinase and its impact on renal function in patients undergoing complex partial nephrectomy
To identify the risk factors associated with development of postoperative elevation of creatine kinase (CK) and study its effect on renal function in patients who underwent complex multifocal partial nephrecto...
-
Article
Therapeutic Strategies for Hereditary Kidney Cancer
The study of hereditary forms of kidney cancer has vastly increased our understanding of metabolic and genetic pathways involved in the development of both inherited and sporadic kidney cancers. The recognitio...
-
Article
Role of 1 week of antibiotic prophylaxis before percutaneous nephrolithotomy
-
Article
Determinants of outcomes after resection of renal cell carcinoma with venous involvement
To determine the outcomes and to identify prognostic variables determining mortality and recurrence after surgery for renal cell cancer (RCC) with venous involvement.